You are now leaving the Lilly Medical Education website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.
How do you select therapy for patients with CLL?
Dr. Lindsey Roeker and Dr. Meghan Thompson discuss their considerations when selecting therapy for patients with CLL.
Date of Last Review: February 9, 2024
Document Number: VV-MED-143939
Related Resources
Infographic for HCPs describing indications for treating CLL and current therapies.
Infographic for HCPs reviewing testing and prognostic value of CLL biomarkers.
Infographic for HCPS on strategies for infection prevention and reducing the incidence of secondary primary malignancies in patients with CLL.
Infographic for HCPs to counsel patients with CLL about infection prevention, staying up to date with vaccines, and screening for secondary primary malignancies.
Infographic for HCPs on navigating social support and educational resources for patients with CLL.
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied